Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.
Also called NCT02923115
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 134 participants
- Sponsor
- Registry
-
NCT02923115 -
2015-005211-32
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria, Belgium, France, Germany, Italy, Netherlands, Spain
- Registry status
- Completed
Technical summary
Registry record NCT02923115. Randomized; double masking; primary purpose treatment. Start 2016-06-23 (actual); primary completion 2019-08-05 (actual). Results posted on 2020-07-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
- Condition
- Pulmonary Embolism
- Condition
- Thrombotic Disease
- Intervention (Drug)
- DS-1040b
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Enoxaparin
- Lead sponsor
- Daiichi Sankyo
Record details
- Record id
cardio:ct-nct02923115- Content hash
3e884e310fd413828df46f40af6802ef0f8cb2d154c7a476083675631548ff21